🇺🇸 FDA
Patent

US 10351522

Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof

granted A61KA61K31/18A61K31/341

Quick answer

US patent 10351522 (Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof) held by The Board of Regents of the University of Texas System expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/18, A61K31/341, A61K31/36, A61K31/381